Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
318 participants
INTERVENTIONAL
2021-05-10
2025-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Feasibility of the ELIOS System in POAG Patients
NCT05999006
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
NCT02829996
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
NCT00069706
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02636946
A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study
NCT03216902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ELIOS Procedure
ELIOS Procedure
ELIOS Procedure
Treatment with the ELIOS System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ELIOS Procedure
Treatment with the ELIOS System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Operable cataract, eligible for phacoemulsification with a BCVA of 20/40 or worse
* Medicated IOP of \<=24 mmHg
* Unmedicated diurnal IOP of \>=22 mmHg and \<=34 mmHg
* Shaffer angle grade of III or IV
* CD ratio \<=0.8
* At least 45 years old
Exclusion Criteria
* Prior incisional glaucoma surgery, intraocular surgery, or corneal surgery
* Cannot undergo medication washout in the study eye
* Diagnosis of degenerative visual disorders
* Non-study eye with BCVA worse than 20/80
* Known corticosteroid responder
* Pregnant or nursing women; or women of childbearing potential not using medically acceptable birth control
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elios Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iqbal (Ike) Ahmed, MD
Role: STUDY_DIRECTOR
Prism Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ELIOS Vision Clinical Site
Glendale, Arizona, United States
ELIOS Vision Clinical Site
Petaluma, California, United States
ELIOS Vision Clinical Site
Fort Collins, Colorado, United States
ELIOS Vision Clinical Site
Grand Junction, Colorado, United States
ELIOS Vision Clinical Site
DeLand, Florida, United States
ELIOS Vision Clinical Site
Largo, Florida, United States
ELIOS Vision Clinical Site
Melbourne, Florida, United States
ELIOS Vision Clinical Site
Vero Beach, Florida, United States
ELIOS Vision Clinical Site
Rock Island, Illinois, United States
ELIOS Vision Clinical Site
Overland Park, Kansas, United States
ELIOS Vision Clinical Site
Chaska, Minnesota, United States
ELIOS Vision Clinical Site
St Louis, Missouri, United States
ELIOS Vision Clinical Site
Las Vegas, Nevada, United States
ELIOS Vision Clinical Site
South Orange, New Jersey, United States
ELIOS Vision Clinical Site
Oklahoma City, Oklahoma, United States
ELIOS Vision Clinical Site
Duncanville, Texas, United States
ELIOS Vision Clinical Site
El Paso, Texas, United States
Elios Vision Clinical Site 2
San Antonio, Texas, United States
ELIOS Vision Clinical Site
San Antonio, Texas, United States
ELIOS Vision Clinical Site
Kenosha, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EP-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.